For citations:
Kolbin A.S., Vilyum I.A., Proskurin M.A., Balikina Yu.E., Pavlysh A.V. Pharmacoeconomic analysis of atezolizumab plus nab-paclitaxel in the treatment of the advanced or metastatic triple-negative breast cancer. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2020;(1):4-21. (In Russ.) https://doi.org/10.37489/2588-0519-2020-1-4-21